VIAVI Solutions Medication Verification System Using Spectrometry
Summary
USPTO granted patent US12603167B2 to VIAVI Solutions Inc. on April 14, 2026. The patent covers a medication assurance system that uses a portable spectrometer to obtain light spectra of medications and performs chemometric analysis to identify medications. The system also incorporates biometric patient identification to verify medication appropriateness for individual patients.
What changed
USPTO issued patent US12603167B2 to VIAVI Solutions Inc. for a medication assurance system combining portable spectrometry with patient biometric verification. The system obtains light spectra from medications, performs chemometric analysis to identify the medication, and cross-references patient identity via biometric device to confirm medication appropriateness.
For investors and manufacturers in medical device technology, this patent establishes IP protection for integrated medication verification combining spectroscopic analysis with patient identification. Companies developing or planning to develop similar medication verification systems should consider potential infringement implications and may seek licensing discussions with VIAVI Solutions.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Medication assurance system and method
Grant US12603167B2 Kind: B2 Apr 14, 2026
Assignee
VIAVI Solutions Inc.
Inventors
Nada A. O'Brien, Christopher G. Pederson
Abstract
A medication assurance system for verification of both the medication and the patient is disclosed. A portable spectrometer is used to obtain a light spectrum of the medication. A subject identification or biometric device is used to identify the patient. A controller coupled to the portable spectrometer and the subject identification device identifies the medication by performing a chemometric analysis of the light spectrum. Based on the medication identified and the patient identified, the controller can determine if the medication is to be taken by the patient.
CPC Classifications
G16H 20/13 G16H 10/60 G16H 20/10 G16H 40/63 A61J 7/0076 A61J 7/04 G01J 3/00 G01J 3/26 G01J 3/2803 G01J 3/42 G01N 21/3563 G01N 21/359 G01N 21/9508 G01N 2201/0221 G01N 2201/129 G04C 21/16
Filing Date
2020-09-16
Application No.
16948386
Claims
21
Related changes
Get daily alerts for USPTO Patent Grants - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.